Psychedelics
Mental health and finding alternative ways to improve health and wellness are at the forefront for many people today. While people have turned to what Westernized medicine considers traditional pharmaceuticals, the psychedelics industry is quickly leading the charge as an alternative for mental health treatments.
Even with the psychedelics industry in its nascency, the opportunities that exist across the value chain are quickly being uncovered by early adopters in the sector. Whether you are producing psychedelics for clinical treatments, operating a clinical or treatment center, creating nutraceutical or wellness products, or developing medical tourism experiences, the path to commercial success will require you to navigate this emerging and highly regulated sector.
In the psychedelics sector, the potential for rewards comes with many considerations when venturing into unchartered territory. Your path to success in psychedelics includes high barriers to entry and complex legal and regulatory hurdles. MNP’s highly qualified professionals are well-versed in emerging sectors and can help you to navigate these challenges and find your path to success.
MNP can help the psychedelics sector:
- Conduct informative market research and prepare an effective business plan
- Prepare statements for seeking financing, meeting regulatory requirements, forming key partnerships, generating cash flow, minimizing taxes.
- Build profitability, expand the scope of your organization, and undergo significant transactions – such as going public or M&A
- Access the knowledge guidance crucial to successfully navigate the path forward.
Solutions for Your Success
The psychedelics sector is young, entrepreneurial and rapidly evolving – and brimming with potential. Learn how MNP can help guide you to sustainable growth and success.
-
Conducting research and development activities in the psychedelics sector could qualify you for SR&ED credits. Learn more about SR&ED here.
-
Going public can support your growth objectives by helping you access new markets, increase publicity and elevate your business’ image. Learn more about Going Public here.
Insights
-
Performance
March 16, 2022
Case Studies: Performance Improvement in the Food and Beverage Industry
MNP builds customized solutions to help clients in the food and beverage sector drive success and profitability, no matter their size or reach in the market.
-
June 03, 2020
Cannabis 3.0: Part 2 - A Starter's Guide
Contact Our Food and Beverages Processing Team
Glenn Fraser CPA, CA, MBA
VP, National Leader, Food & Beverage Processing
Glenn Fraser, CPA, CA, MBA, is the National Leader of MNP’s Food and Beverage Processing practice and leader of the firm’s Cannabis Services team. An active member in both the food and beverage processing and cannabis industries, Glenn provides value to his clients and to clients of MNP by drawing on 25 years of experience in providing effective business advisory, tax and assurance services to private company entrepreneurs and subsidiaries of international businesses operating in Canada.
In addition, Glenn has played an instrumental role in various economic impact assessments, feasibility studies and strategic projects for industry leaders, including Food and Beverage Ontario, BC Food Processors Association, Ontario Agri Business Association, Ontario Craft Cider and Ontario Agri-Food Technologies.
Glenn has also published numerous articles in Food in Canada magazine and maintains an influential role in the annual Canadian Food Industry Report.
As a leader in the Canadian cannabis sector, Glenn frequently partners with top CEOs and leaders to tackle diverse topics surrounding the key issues and opportunities in the industry.
Having attained his Master of Business Administration (MBA) degree from York University, Glenn went on to become a Chartered Professional Accountant (CPA), qualifying as a Chartered Accountant (CA). Glenn currently sits on MNP’s Board of Directors where he helps drive the firm’s strategy and growing prominence in a vastly competitive field. He also acts as chair and board member of Childhood Cancer Canada.